We give you a written timeline estimate for your case before you commit.Ask about Elevidys
Is Elevidys available in Saudi Arabia? Status, route and cost
A plain answer for families in Saudi Arabia, checked against FDA, regulator and manufacturer sources on 17 October 2026.
Reviewed by the Reserve Meds clinical operations team on 17 October 2026.
Is Elevidys available in Saudi Arabia?
Elevidys is not in SFDA's public Drugs List (checked 17 October 2026). It is a one-time gene therapy for Duchenne muscular dystrophy in boys who can walk, given only at specialized centers. The realistic routes are a qualified center abroad, or a hospital import if the manufacturer agrees and SFDA approves.
- Registration: Not found in the SFDA public Drugs List when we searched all 9,173 entries by brand and generic name on 17 October 2026.
- Access route: Treatment at a qualified center abroad, or a hospital import request to SFDA if the manufacturer agrees.
- Who acts: your specialist refers the patient abroad; a hospital in Saudi Arabia applies to SFDA only if the manufacturer agrees to supply it.
- Timeline: We give you a written timeline estimate for your case before you commit.
- Medicine price: quote on request. Every case gets a written custom quote before you commit.
Status in Saudi Arabia, with dates
- Elevidys was not found in the SFDA public Drugs List on 17 October 2026 (searched by brand and generic name). (source)
What Elevidys is
Elevidys (delandistrogene moxeparvovec) is made by Sarepta Therapeutics (Roche outside the US). Since the FDA's update of 14 November 2025, Elevidys is approved in the US for ambulatory patients (those who can still walk) aged 4 years and older with a confirmed mutation in the DMD gene. The FDA removed non-ambulatory patients after deaths from acute liver failure, and added a boxed warning for acute serious liver injury and acute liver failure.
How it is given: A single intravenous (IV) infusion at a qualified center, after tests for antibodies to the virus used to deliver the gene, and with close liver monitoring afterwards. The boxed warning means the treating team will check liver health before treatment and follow it closely after.
How access works in Saudi Arabia
Elevidys is given only at specialized treatment centers. It is not a medicine a family can collect, or a clinic can give in an outpatient room.
For a family in Saudi Arabia, that leaves two realistic routes. First, treatment at a qualified center abroad, after your specialist refers you and the center accepts the patient. Second, a hospital in Saudi Arabia asks the manufacturer, Sarepta Therapeutics (Roche outside the US), whether it will supply that hospital. If the manufacturer agrees, the hospital still needs import approval from the Saudi Food and Drug Authority (SFDA). We cannot promise that a manufacturer will agree.
How a hospital import request works in Saudi Arabia, if it is ever needed:
Because Elevidys is approved by the US FDA, a licensed Saudi hospital can ask SFDA for permission to import it for one named patient. This is often called the named-patient route.
SFDA expects the medicine to be registered with at least one reference regulator, such as the US FDA or the European Medicines Agency. The hospital signs a declaration that it takes responsibility for safe use. A licensed importer signs a declaration covering quality during transport. The patient or a legal guardian gives written consent after the treating doctor explains the benefits and risks.
SFDA's Special Access Program is a different route, for medicines with no reference approval anywhere, such as products still in clinical trials. Elevidys does not need that route because it already has FDA approval.
Public lists can lag behind registration decisions, so the hospital pharmacy confirms the status in SFDA's system before anything is filed.
Who does what
- Your treating specialist decides whether Elevidys is right for the patient and writes the referral or prescription.
- The hospital or treatment center checks eligibility, plans treatment and is responsible for giving it safely.
- The Saudi Food and Drug Authority (SFDA) registers medicines and decides on any import request for a medicine that is not registered.
- Sarepta Therapeutics (Roche outside the US) makes Elevidys and decides where it can be supplied.
- Reserve Meds helps your family understand the steps, organizes records and communication, and, where an import is needed, arranges US supply through our licensed wholesale partner. We do not give medical advice.
Documents you will usually need
- Genetic confirmation of the DMD mutation, a recent assessment showing the boy can walk, and baseline liver tests
- A referral letter from the treating specialist with the diagnosis, past treatments and why this treatment is being considered
- Recent clinic notes, imaging and laboratory results
- Identity documents and a funding plan (personal funds, insurer approval or a government treatment decision)
- Passport and travel documents, if treatment happens abroad
Steps
- Referral. Your specialist prepares a referral letter and the medical records.
- Center review. A qualified treatment center reviews the records and decides whether the patient is eligible.
- Funding. The family confirms funding with the center, an insurer or a government program.
- Preparation. The center runs tests and, for cell-based products, collects cells to make the treatment.
- Treatment and follow-up. The patient is treated and then followed up by the center and the home specialist.
Timeline and cost
We give you a written timeline estimate for your case before you commit. The treating center, the regulator and the manufacturer set their own timelines.
Medicine price: quote on request. Your total cost depends on the dose, travel or shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.
How Reserve Meds helps
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We coordinate access to FDA-approved medicines only. We help your family understand the route, organize records and communication with the hospital or center, and, where an import is approved, arrange US supply and shipping. We do not prescribe, and we do not decide what the regulator or a treatment center approves.
Ask about Elevidys in Saudi Arabia
Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.
Frequently asked questions
Is Elevidys registered in Saudi Arabia?
Elevidys is not in SFDA's public Drugs List (checked 17 October 2026). Public lists can lag behind registration decisions, so the hospital pharmacy confirms the status in SFDA's system before anything is filed.
How do patients in Saudi Arabia get Elevidys?
It is a one-time gene therapy for Duchenne muscular dystrophy in boys who can walk, given only at specialized centers. The realistic routes are a qualified center abroad, or a hospital import if the manufacturer agrees and SFDA approves.
How long does it take to get Elevidys in Saudi Arabia?
We give you a written timeline estimate for your case before you commit. The treating center, the regulator and the manufacturer set their own timelines, and we tell you honestly what depends on them.
How much does Elevidys cost?
Medicine price: quote on request. Your total cost, including any travel, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.
Can Elevidys be given in Saudi Arabia instead of abroad?
Only if a center in Saudi Arabia offers it, or the manufacturer agrees to supply a hospital there and SFDA approves the import. We will tell you honestly if that is not possible today.
Sources
Checked on 17 October 2026. Regulator rules and lists change. Your hospital pharmacy or treatment center confirms the current position before anything is filed.
- FDA: ELEVIDYS (delandistrogene moxeparvovec-rokl) product page and safety communications (boxed warning and revised indication, 14 Nov 2025)
- SFDA: public Drugs List (all 9,173 entries searched by brand and generic name on 17 Oct 2026)
- PharmaKnowl: Named Patient Program in Saudi Arabia (reference regulators, hospital and importer declarations, patient consent)
- SFDA: Special Access Program (SAP) guidance, version 1.0